Divergence bias in Hess compared to Harms screen strabismus testing.

Harms test Hess test prism cover test strabismus tangent screen test vergence

Journal

Strabismus
ISSN: 1744-5132
Titre abrégé: Strabismus
Pays: England
ID NLM: 9310896

Informations de publication

Date de publication:
03 2021
Historique:
pubmed: 17 2 2021
medline: 21 10 2021
entrez: 16 2 2021
Statut: ppublish

Résumé

The Hess and the Harms screen test each have different testing distances. While the Harms screen test is usually performed at 2.5 m, the Hess screen test is performed at 0.5 m. The geometry of the closer testing distance of the Hess screen test requires an increase of the convergence angle by 6°. This study investigates the quantitative differences between the two frequently employed screen tests. Ocular deviation of 18 normal subjects and 36 patients with congenital or acquired paralytic or concomitant strabismus were assessed with a complete orthoptic examination including alternate prism cover testing at near (nPCT) and far (fPCT), as well as Hess and Harms screen testing. One-way ANOVA was used for statistical analysis. The Hess test recorded more overall exodeviation compared to the Harms test for patients (mean difference -3.50°, 95% limits of agreement (CI) = [-4.79, -2.21],

Identifiants

pubmed: 33591220
doi: 10.1080/09273972.2020.1871382
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1-9

Auteurs

Muriel Dysli (M)

Department of Ophthalmology, University Hospital Zurich, University of Zurich, Zurich.
Department of Neurology, University Hospital Zurich, University of Zurich, Zurich.

Fabienne C Fierz (FC)

Department of Ophthalmology, University Hospital Zurich, University of Zurich, Zurich.

Daniel Rappoport (D)

Department of Ophthalmology, University Hospital Zurich, University of Zurich, Zurich.

Tanja Schmückle Meier (TS)

Department of Ophthalmology, University Hospital Zurich, University of Zurich, Zurich.

Klara Landau (K)

Department of Ophthalmology, University Hospital Zurich, University of Zurich, Zurich.

Christopher J Bockisch (CJ)

Department of Ophthalmology, University Hospital Zurich, University of Zurich, Zurich.
Department of Neurology, University Hospital Zurich, University of Zurich, Zurich.
Department of Otorhinolaryngology, Head & Neck Surgery, University Hospital Zurich, University of Zurich, Zurich.

Konrad P Weber (KP)

Department of Ophthalmology, University Hospital Zurich, University of Zurich, Zurich.
Department of Neurology, University Hospital Zurich, University of Zurich, Zurich.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH